AMI‑CryoML

Integrating cryo‑EM and ML to decode amyloid fibril polymorphism.

🧠 AMI‑CryoML: unraveling amyloid polymorphism

Cracking the code of amyloid polymorphism: integrating cryoEM and machine learning to unravel impact of small aggregation modulators on amyloid fibril polymorphism

PI: Jarek
Funding agency: European Commission | European Research Executive Agency
Programme: Horizon Europe | WIDERA | ERA Fellowships
Grant ID: 101244706
Start date: 1 Feb 2026
Duration: 24 months
Budget: €181,136.16

Neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and prion diseases are marked by protein misfolding into amyloid fibrils. The structural diversity (polymorphism) of these fibrils critically affects their pathology, yet remains largely unexplored. AMI‑CryoML bridges cryo‑EM and machine learning to probe how small molecule modulators influence aggregation kinetics and amyloid structures.

📌 Project highlights

  • 🔍 Systematic collection of aggregation modulators: chemical and mechanistic profiling
  • 🧪 Thioflavin‑T assays to measure kinetic effects across proteins (prions, CsgA, α‑synuclein)
  • 🧬 Cryo‑EM to resolve fibril polymorphs under varied conditions
  • 💾 Extension of the AmyloGraph database to store modulator‑kinetics‑structure data
  • 🤖 Machine learning models to predict modulator effects